Literature DB >> 29556018

Pegylated interferon Alfa-2a and hydroxyurea in polycythemia vera and essential thrombocythemia: differential cellular and molecular responses.

Tsewang Tashi1, Sabina Swierczek1, Soo Jin Kim1, Mohamed E Salama2, Jihyun Song1, Nahla Heikal2, Katherine Y King3, Kim Hickman1, Scott Litton1, Josef T Prchal4,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29556018      PMCID： PMC6552660          DOI： 10.1038/s41375-018-0080-6

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  5 in total

1.  Thrombotic, inflammatory, and HIF-regulated genes and thrombosis risk in polycythemia vera and essential thrombocythemia.

Authors:  Radhika Gangaraju; Jihyun Song; Soo Jin Kim; Tsewang Tashi; Brandi N Reeves; Krishna M Sundar; Perumal Thiagarajan; Josef T Prchal
Journal:  Blood Adv       Date:  2020-03-24

2.  Germline genetic factors influence the outcome of interferon-α therapy in polycythemia vera.

Authors:  Roland Jäger; Heinz Gisslinger; Elisabeth Fuchs; Edith Bogner; Jelena D Milosevic Feenstra; Jakob Weinzierl; Fiorella Schischlik; Bettina Gisslinger; Martin Schalling; Michael Zörer; Kurt Krejcy; Christoph Klade; Robert Kralovics
Journal:  Blood       Date:  2021-01-21       Impact factor: 22.113

Review 3.  Yin and Yang: The dual effects of interferons on hematopoiesis.

Authors:  Yasmin Demerdash; Bailee Kain; Marieke A G Essers; Katherine Y King
Journal:  Exp Hematol       Date:  2021-02-08       Impact factor: 3.084

4.  Data-driven analysis of JAK2V617F kinetics during interferon-alpha2 treatment of patients with polycythemia vera and related neoplasms.

Authors:  Rasmus K Pedersen; Morten Andersen; Trine A Knudsen; Zamra Sajid; Johanne Gudmand-Hoeyer; Marc J B Dam; Vibe Skov; Lasse Kjaer; Christina Ellervik; Thomas S Larsen; Dennis Hansen; Niels Pallisgaard; Hans C Hasselbalch; Johnny T Ottesen
Journal:  Cancer Med       Date:  2020-01-28       Impact factor: 4.452

5.  Conventional interferon-α 2b versus hydroxyurea for newly-diagnosed patients with polycythemia vera in a real world setting: a retrospective study based on 286 patients from a single center.

Authors:  Dan Liu; Zefeng Xu; Peihong Zhang; Tiejun Qin; Xiujuan Sun; Shiqiang Qu; Lijuan Pan; Jiao Ma; Wenyu Cai; Jinqin Liu; Huijun Wang; Qi Sun; Zhongxun Shi; Huijun Huang; Gang Huang; Robert Peter Gale; Bing Li; Raajit K Rampal; Zhijian Xiao
Journal:  Haematologica       Date:  2022-04-01       Impact factor: 11.047
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.